[
  {
    "ts": "2025-10-17T20:45:51+00:00",
    "headline": "S&P 500 Posts Weekly Gain on Tariff Optimism, Better-Than-Expected Earnings",
    "summary": "The Standard & Poor's 500 index rose 1.7% this week as earnings season kicked off on a largely posit",
    "url": "https://finance.yahoo.com/news/p-500-posts-weekly-gain-204551897.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "272e227b-00d5-3862-a12e-09191a6c529d",
      "content": {
        "id": "272e227b-00d5-3862-a12e-09191a6c529d",
        "contentType": "STORY",
        "title": "S&P 500 Posts Weekly Gain on Tariff Optimism, Better-Than-Expected Earnings",
        "description": "",
        "summary": "The Standard & Poor's 500 index rose 1.7% this week as earnings season kicked off on a largely posit",
        "pubDate": "2025-10-17T20:45:51Z",
        "displayTime": "2025-10-17T20:45:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/p-500-posts-weekly-gain-204551897.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/p-500-posts-weekly-gain-204551897.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "GS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T16:20:27+00:00",
    "headline": "J&J’s Tecvayli-Darzalex trumps SoC in multiple myeloma",
    "summary": "If the combination were to be approved, Tecvayli would expand out from its traditional role in fourth line treatment and beyond.",
    "url": "https://www.clinicaltrialsarena.com/news/johnson-johnson-tecvayli-darzalex-faspro-multiple-myeloma-phase-iii/",
    "source": "Clinical Trials Arena",
    "provider": "yfinance",
    "raw": {
      "id": "b99b22fc-9630-37db-8057-f47de9d76205",
      "content": {
        "id": "b99b22fc-9630-37db-8057-f47de9d76205",
        "contentType": "STORY",
        "title": "J&J’s Tecvayli-Darzalex trumps SoC in multiple myeloma",
        "description": "",
        "summary": "If the combination were to be approved, Tecvayli would expand out from its traditional role in fourth line treatment and beyond.",
        "pubDate": "2025-10-17T16:20:27Z",
        "displayTime": "2025-10-17T16:20:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/clinical_trials_arena_396/4f72734dee56a7ab9ce1af0e0f4cb0e7",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Johnson & Johnson's targeted therapeutic combination",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KyKrG7cqF.prdQ7gm7U.Sw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/clinical_trials_arena_396/4f72734dee56a7ab9ce1af0e0f4cb0e7.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l5QreWdn_m69Dh.cDQGu6A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/clinical_trials_arena_396/4f72734dee56a7ab9ce1af0e0f4cb0e7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Clinical Trials Arena",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.clinicaltrialsarena.com/news/johnson-johnson-tecvayli-darzalex-faspro-multiple-myeloma-phase-iii/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-tecvayli-darzalex-trumps-162027380.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T16:11:00+00:00",
    "headline": "Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?",
    "summary": "JNJ's strong Q3 results, upbeat sales outlook and expanding drug pipeline highlight resilience despite Stelara LOE.",
    "url": "https://finance.yahoo.com/news/buy-sell-hold-j-j-161100770.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c4d54ccd-bec6-3a7a-b19d-a5427b5df0f9",
      "content": {
        "id": "c4d54ccd-bec6-3a7a-b19d-a5427b5df0f9",
        "contentType": "STORY",
        "title": "Should You Buy, Sell or Hold J&J Stock After Robust Q3 Earnings?",
        "description": "",
        "summary": "JNJ's strong Q3 results, upbeat sales outlook and expanding drug pipeline highlight resilience despite Stelara LOE.",
        "pubDate": "2025-10-17T16:11:00Z",
        "displayTime": "2025-10-17T16:11:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tugIemz.T.iquqxVIoxpHw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SHyaOdZAc4DXCya2O4.DtQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-j-j-161100770.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-j-j-161100770.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T13:24:00+00:00",
    "headline": "Diorasis Therapeutics Welcomes Dr. Dimitri Azar to Its Board of Directors",
    "summary": "BOSTON, October 17, 2025--Diorasis Therapeutics Welcomes Dr. Dimitri Azar to Its Board of Directors",
    "url": "https://finance.yahoo.com/news/diorasis-therapeutics-welcomes-dr-dimitri-132400568.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "c57427f4-887c-3e8d-b9dd-571924b170dc",
      "content": {
        "id": "c57427f4-887c-3e8d-b9dd-571924b170dc",
        "contentType": "STORY",
        "title": "Diorasis Therapeutics Welcomes Dr. Dimitri Azar to Its Board of Directors",
        "description": "",
        "summary": "BOSTON, October 17, 2025--Diorasis Therapeutics Welcomes Dr. Dimitri Azar to Its Board of Directors",
        "pubDate": "2025-10-17T13:24:00Z",
        "displayTime": "2025-10-17T13:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/c719dbd453ecd5873031fc447ecb04ed",
          "originalWidth": 480,
          "originalHeight": 211,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JCIM8yzc.Eppy0Yh78JDvw--~B/aD0yMTE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c719dbd453ecd5873031fc447ecb04ed.cf.webp",
              "width": 480,
              "height": 211,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XaD3T0AaHqDKKppyYMDiig--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/c719dbd453ecd5873031fc447ecb04ed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/diorasis-therapeutics-welcomes-dr-dimitri-132400568.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/diorasis-therapeutics-welcomes-dr-dimitri-132400568.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NOVN.SW"
            },
            {
              "symbol": "GOOGL"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T12:13:54+00:00",
    "headline": "J&J Myeloma Combo Hits Late-Stage Goal",
    "summary": "Combo beats investigator choice in relapsed setting",
    "url": "https://finance.yahoo.com/news/j-j-myeloma-combo-hits-121354929.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "b61c4f21-32a3-371a-b9c5-3d237b0e7dac",
      "content": {
        "id": "b61c4f21-32a3-371a-b9c5-3d237b0e7dac",
        "contentType": "STORY",
        "title": "J&J Myeloma Combo Hits Late-Stage Goal",
        "description": "",
        "summary": "Combo beats investigator choice in relapsed setting",
        "pubDate": "2025-10-17T12:13:54Z",
        "displayTime": "2025-10-17T12:13:54Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/a631149e008fe04bcad182a629a22c2e",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nQahFoVt6_qKzx8G6FoELg--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a631149e008fe04bcad182a629a22c2e.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yScmCasUkPZyvdIPPU4j.w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/a631149e008fe04bcad182a629a22c2e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-j-myeloma-combo-hits-121354929.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-myeloma-combo-hits-121354929.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T11:34:52+00:00",
    "headline": "HistoSonics raises $250m to support commercial expansion",
    "summary": "The funding tranche follows HistoSonics’ $2.25bn acquisition by an investor consortium in August.",
    "url": "https://www.medicaldevice-network.com/news/histosonics-raises-250m-to-support-commercial-expansion/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "acceae5b-afda-31ab-85e5-0769859fe421",
      "content": {
        "id": "acceae5b-afda-31ab-85e5-0769859fe421",
        "contentType": "STORY",
        "title": "HistoSonics raises $250m to support commercial expansion",
        "description": "",
        "summary": "The funding tranche follows HistoSonics’ $2.25bn acquisition by an investor consortium in August.",
        "pubDate": "2025-10-17T11:34:52Z",
        "displayTime": "2025-10-17T11:34:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/eb064be185577c19e2d0309348d37a9e",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "HistoSonics' Edison system is the first and only histotripsy system approved for clinical use globally. Image credit: HistoSonics/Businesswire",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hh.ebrPRHXYflRtRixEHNw--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/eb064be185577c19e2d0309348d37a9e.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JdzicP_qyE_yoTbyiIZzFw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/eb064be185577c19e2d0309348d37a9e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/histosonics-raises-250m-to-support-commercial-expansion/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/histosonics-raises-250m-support-commercial-113452816.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T09:11:32+00:00",
    "headline": "Ulta Beauty names Christopher DelOrefice as new CFO",
    "summary": "Chris Lialios will continue as interim CFO until DelOrefice assumes the position in December 2025",
    "url": "https://www.retail-insight-network.com/news/ulta-beauty-christopher-delorefice-cfo/",
    "source": "Retail Insight Network",
    "provider": "yfinance",
    "raw": {
      "id": "5ae0ef6f-f4fd-3996-837a-81a42aab5f9d",
      "content": {
        "id": "5ae0ef6f-f4fd-3996-837a-81a42aab5f9d",
        "contentType": "STORY",
        "title": "Ulta Beauty names Christopher DelOrefice as new CFO",
        "description": "",
        "summary": "Chris Lialios will continue as interim CFO until DelOrefice assumes the position in December 2025",
        "pubDate": "2025-10-17T09:11:32Z",
        "displayTime": "2025-10-17T09:11:32Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/retail_insight_network_724/695fa16899dd882ca336fb1239dd363a",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "Before joining Becton Dickinson",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lfm8N0NWl5lEphC3wRzGdg--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/retail_insight_network_724/695fa16899dd882ca336fb1239dd363a.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uC1UVZgVOm4P7xqNyZw_oA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/retail_insight_network_724/695fa16899dd882ca336fb1239dd363a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Retail Insight Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.retail-insight-network.com/news/ulta-beauty-christopher-delorefice-cfo/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ulta-beauty-names-christopher-delorefice-091132929.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ULTA"
            },
            {
              "symbol": "BDX"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-17T05:54:28+00:00",
    "headline": "HistoSonics raises $250M to expand use of noninvasive cancer therapy",
    "summary": "The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion of its technology.",
    "url": "https://www.medtechdive.com/news/histosonics-fudning-round-250m/803080/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "8a33b581-dcef-3a9b-85e5-ed7bdf0a3bfe",
      "content": {
        "id": "8a33b581-dcef-3a9b-85e5-ed7bdf0a3bfe",
        "contentType": "STORY",
        "title": "HistoSonics raises $250M to expand use of noninvasive cancer therapy",
        "description": "",
        "summary": "The company raised money from Bezos Expeditions, Thiel Bio and other investors to fund the commercial and clinical expansion of its technology.",
        "pubDate": "2025-10-17T05:54:28Z",
        "displayTime": "2025-10-17T05:54:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "MedTech Dive, an Industry Dive publication",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CfiwZcqajD6GIrfQSU8QEw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jrfLJxLAsCtfuwsqFT5_ww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/750fdf53cb35947d5f0ce8a43a826421.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/histosonics-fudning-round-250m/803080/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/histosonics-raises-250m-expand-noninvasive-055428626.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]